IART
IART
NASDAQ · Health Care

Integra Lifesciences Holding

$11.26
+0.38 (+3.49%)
As of Feb 8, 1:44 PM ET ·
Income Statement
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Revenue 1.63B 1.61B 269.40M 284.27M 289.60M
Net Income -7,025,868 -6,232,904 40.15M 41.42M 44.34M
EPS
Profit Margin -0.4% -0.4% 14.9% 14.6% 15.3%
Rev Growth +1.5% +1.5% +5.9% +23.9% +16.2%
Balance Sheet
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Total Debt 236.15M 236.15M 112.35M 104.07M 110.88M
Total Equity 202.39M 202.39M 311.19M 274.89M 305.05M
D/E Ratio 1.17 1.17 0.36 0.38 0.36
Cash Flow
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
EBITDA 47.08M 44.08M 75.51M 83.90M 77.61M
Free Cash Flow 36.78M 47.45M 57.75M